|
|
|
Insider
Information: |
Moretti August J |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
137,329 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$90,825 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
137,329 |
|
|
Total
Value |
$90,825 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alexza Pharmaceuticals Inc. |
ALXA |
Former SVP, CFO, GC & ... |
2011-08-31 |
51,837 |
|
0 |
Premium* |
|
Assertio Holdings Inc |
ASRT |
Chief Financial Office... |
2018-03-31 |
74,447 |
2013-05-17 |
0 |
Premium* |
|
4d Molecular Therapeutics Inc. |
FDMT |
|
2023-05-15 |
11,045 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FDMT |
4d Molecular Therapeutics... |
See RemarksOfficer |
|
2020-12-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
FDMT |
4d Molecular Therapeutics... |
Chief Financial Officer |
|
2021-04-12 |
4 |
OE |
$9.41 |
$9,410 |
D/D |
1,000 |
2,000 |
0 |
- |
|
FDMT |
4d Molecular Therapeutics... |
Chief Financial Officer |
|
2022-12-21 |
4 |
OE |
$9.41 |
$28,230 |
D/D |
3,000 |
6,595 |
0 |
- |
|
FDMT |
4d Molecular Therapeutics... |
Chief Financial Officer |
|
2023-05-15 |
4 |
OE |
$9.41 |
$28,230 |
D/D |
3,000 |
11,045 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer |
|
2013-05-17 |
4 |
OE |
$5.35 |
$13,375 |
D/D |
2,500 |
3,752 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer |
|
2013-12-02 |
4 |
AS |
$8.40 |
$23,709 |
D/D |
(2,821) |
11,214 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer |
|
2014-12-02 |
4 |
AS |
$15.85 |
$84,639 |
D/D |
(5,339) |
22,564 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2015-12-01 |
4 |
D |
$19.00 |
$139,251 |
D/D |
(7,329) |
36,319 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2015-12-03 |
4 |
AS |
$18.01 |
$271,597 |
D/D |
(15,000) |
21,319 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2015-12-16 |
4 |
OE |
$5.35 |
$26,750 |
D/D |
5,000 |
26,319 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2016-04-02 |
4 |
D |
$14.38 |
$13,517 |
D/D |
(940) |
27,879 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2016-05-09 |
4 |
AS |
$18.00 |
$90,000 |
D/D |
(5,000) |
22,879 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2016-08-10 |
4 |
AS |
$21.40 |
$107,000 |
D/D |
(5,000) |
21,680 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2016-08-10 |
4 |
OE |
$12.69 |
$41,839 |
D/D |
3,297 |
24,977 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2016-11-14 |
4 |
AS |
$20.84 |
$104,200 |
D/D |
(5,000) |
21,680 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2016-11-14 |
4 |
OE |
$12.69 |
$63,450 |
D/D |
5,000 |
26,680 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2016-12-01 |
4 |
D |
$18.55 |
$201,323 |
D/D |
(10,853) |
40,225 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2017-04-02 |
4 |
D |
$12.55 |
$11,797 |
D/D |
(940) |
41,785 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2017-12-01 |
4 |
D |
$7.11 |
$73,489 |
D/D |
(10,336) |
58,949 |
0 |
- |
|
ASRT |
Assertio Holdings Inc |
Chief Financial Officer & SVP |
|
2018-03-31 |
4 |
D |
$6.59 |
$45,965 |
D/D |
(6,975) |
74,447 |
0 |
- |
|
ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & SecOfficer |
|
2006-03-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,999 |
|
- |
|
ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
|
2006-12-07 |
4 |
S |
$8.30 |
$16,600 |
D/D |
(2,000) |
5,741 |
0 |
- |
|
ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
|
2007-04-02 |
4 |
AS |
$12.37 |
$123,672 |
D/D |
(10,000) |
5,741 |
0 |
- |
|
ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
|
2007-04-02 |
4 |
OE |
$1.38 |
$13,800 |
D/D |
10,000 |
15,741 |
0 |
- |
|
ALXA |
Alexza Pharmaceuticals In... |
SVP, CFO & Sec |
|
2007-08-01 |
4 |
AS |
$8.66 |
$43,300 |
D/D |
(5,000) |
7,495 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|